4
Changes in Ownership
Xenon Pharmaceuticals Inc. Filed Acc 0001209191-21-020481
Options or other derivatives
- EVP, Strategy & Innovation acquired 65,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
ROBIN SHERRINGTON · EVP, Strategy & Innovation
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-03-12 | Grant or award : show line 1 in the form Stock Option (Right to Buy) | +65,000 | 65,000 | D |
Loading xslF345X03/doc4.xml…